Rapid
progress in disease biomarker discovery has increased the
need for robust detection technologies. In the past several years,
the designs of many immunoaffinity reagents have focused on lowering
costs and improving specificity while also promoting stability. Antibody
fragments (scFvs) have long been displayed on the surface of yeast
and phage libraries for selection; however, the stable production
of such fragments presents challenges that hamper their widespread
use in diagnostics. Membrane and cell wall proteins similarly suffer
from stability problems when solubilized from their native environment.
Recently, cell envelope compositions that maintain membrane proteins
in native or native-like lipid environment to improve their stability
have been developed. This cell envelope composition approach has now
been adapted toward stabilizing antibody fragments by retaining their
native cell wall environment. A new class of immunoaffinity reagents
has been developed that maintains antibody fragment attachment to
yeast cell wall. Herein, we review recent strategies that incorporate
cell wall fragments with functional scFvs, which are designed for
easy production while maintaining specificity and stability when in
use with simple detection platforms. These cell wall based antibody
fragments are globular in structure, and heterogeneous in size, with
fragments ranging from tens to hundreds of nanometers in size. These
fragments appear to retain activity once immobilized onto biosensor
surfaces for the specific and sensitive detection of pathogen antigens.
They can be quickly and economically generated from a yeast display
library and stored lyophilized, at room temperature, for up to a year
with little effect on stability. This new format of scFvs provides
stability, in a simple and low-cost manner toward the use of scFvs
in biosensor applications. The production and “panning”
of such antibody cell wall composites are also extremely facile, enabling
the rapid adoption of stable and inexpensive affinity reagents for
emerging infectious threats.